Further promising agents that are thought to attack BC stem cells are salinomycin, where treatment resulted in the loss of expression of BC stem cells [84], and a new synthetic curcumin analogue against ALDH1 and glycogen synthase kinase-3β [85]. Here, ALDH1A1 is linked to breast cancer.